Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)

Concomitant radiochemotherapy (RTCT) is the standard treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, in patients with a peripheral primary tumor, the irradiated volume may include a large portion of normal lung and RT-CT is not possible. This multicenter phase II tr...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Isabelle Martel-Lafay, Isabelle Monnet, Audrey Lardy-Cleaud, Serge Danhier, Naji Salem, Olivier Gallocher, Pierre Fournel, Christos Chouaid, Olivier Bylicki, the GFPC 01-14 Investigators
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Subjects:	stereotactic body radiation therapy concomitant radiochemotherapy unresectable stage III NSCLC
Online Access:	https://www.mdpi.com/1718-7729/28/5/324